Current Status of Oligonucleotide-Based Protein Degraders

Transcription factors (TFs) and RNA-binding proteins (RBPs) have long been considered undruggable, mainly because they lack ligand-binding sites and are equipped with flat and narrow protein surfaces. Protein-specific oligonucleotides have been harnessed to target these proteins with some satisfacto...

Full description

Bibliographic Details
Main Authors: Po-Chang Shih, Miyako Naganuma, Yosuke Demizu, Mikihiko Naito
Format: Article
Language:English
Published: MDPI AG 2023-02-01
Series:Pharmaceutics
Subjects:
Online Access:https://www.mdpi.com/1999-4923/15/3/765
_version_ 1797609555171999744
author Po-Chang Shih
Miyako Naganuma
Yosuke Demizu
Mikihiko Naito
author_facet Po-Chang Shih
Miyako Naganuma
Yosuke Demizu
Mikihiko Naito
author_sort Po-Chang Shih
collection DOAJ
description Transcription factors (TFs) and RNA-binding proteins (RBPs) have long been considered undruggable, mainly because they lack ligand-binding sites and are equipped with flat and narrow protein surfaces. Protein-specific oligonucleotides have been harnessed to target these proteins with some satisfactory preclinical results. The emerging proteolysis-targeting chimera (PROTAC) technology is no exception, utilizing protein-specific oligonucleotides as warheads to target TFs and RBPs. In addition, proteolysis by proteases is another type of protein degradation. In this review article, we discuss the current status of oligonucleotide-based protein degraders that are dependent either on the ubiquitin–proteasome system or a protease, providing a reference for the future development of degraders.
first_indexed 2024-03-11T06:01:59Z
format Article
id doaj.art-39963b9a532246ed9ff51139ba4749c6
institution Directory Open Access Journal
issn 1999-4923
language English
last_indexed 2024-03-11T06:01:59Z
publishDate 2023-02-01
publisher MDPI AG
record_format Article
series Pharmaceutics
spelling doaj.art-39963b9a532246ed9ff51139ba4749c62023-11-17T13:14:04ZengMDPI AGPharmaceutics1999-49232023-02-0115376510.3390/pharmaceutics15030765Current Status of Oligonucleotide-Based Protein DegradersPo-Chang Shih0Miyako Naganuma1Yosuke Demizu2Mikihiko Naito3Graduate School of Pharmaceutical Sciences, The University of Tokyo, Tokyo 113-0033, JapanNational Institute of Health Sciences, Kawasaki 210-9501, JapanNational Institute of Health Sciences, Kawasaki 210-9501, JapanGraduate School of Pharmaceutical Sciences, The University of Tokyo, Tokyo 113-0033, JapanTranscription factors (TFs) and RNA-binding proteins (RBPs) have long been considered undruggable, mainly because they lack ligand-binding sites and are equipped with flat and narrow protein surfaces. Protein-specific oligonucleotides have been harnessed to target these proteins with some satisfactory preclinical results. The emerging proteolysis-targeting chimera (PROTAC) technology is no exception, utilizing protein-specific oligonucleotides as warheads to target TFs and RBPs. In addition, proteolysis by proteases is another type of protein degradation. In this review article, we discuss the current status of oligonucleotide-based protein degraders that are dependent either on the ubiquitin–proteasome system or a protease, providing a reference for the future development of degraders.https://www.mdpi.com/1999-4923/15/3/765degrader therapeuticstargeted protein degradationPROTACSNIPERnucleic acidsproteases
spellingShingle Po-Chang Shih
Miyako Naganuma
Yosuke Demizu
Mikihiko Naito
Current Status of Oligonucleotide-Based Protein Degraders
Pharmaceutics
degrader therapeutics
targeted protein degradation
PROTAC
SNIPER
nucleic acids
proteases
title Current Status of Oligonucleotide-Based Protein Degraders
title_full Current Status of Oligonucleotide-Based Protein Degraders
title_fullStr Current Status of Oligonucleotide-Based Protein Degraders
title_full_unstemmed Current Status of Oligonucleotide-Based Protein Degraders
title_short Current Status of Oligonucleotide-Based Protein Degraders
title_sort current status of oligonucleotide based protein degraders
topic degrader therapeutics
targeted protein degradation
PROTAC
SNIPER
nucleic acids
proteases
url https://www.mdpi.com/1999-4923/15/3/765
work_keys_str_mv AT pochangshih currentstatusofoligonucleotidebasedproteindegraders
AT miyakonaganuma currentstatusofoligonucleotidebasedproteindegraders
AT yosukedemizu currentstatusofoligonucleotidebasedproteindegraders
AT mikihikonaito currentstatusofoligonucleotidebasedproteindegraders